Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | WZ4002 |
Synonyms | |
Therapy Description |
WZ4002 is a mutant-selective irreversible EGFR inhibitor that inhibits proliferation of tumor cells, including those harboring EGFR T790M (PMID: 20033049, PMID: 31145622). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
WZ4002 | WZ-4002 | EGFR Inhibitor 3rd gen 26 | WZ4002 is a mutant-selective irreversible EGFR inhibitor that inhibits proliferation of tumor cells, including those harboring EGFR T790M (PMID: 20033049, PMID: 31145622). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|